OTCMKTS:ERBA

ERBA Diagnostics Stock Forecast, Price & News

$0.04
0.00 (0.00 %)
(As of 08/27/2020)
Add
Compare
Today's Range
$0.04
$0.04
50-Day Range
$0.04
$0.04
52-Week Range
$0.01
$0.31
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ERBA News and Ratings via Email

Sign-up to receive the latest news and ratings for ERBA Diagnostics and its competitors with MarketBeat's FREE daily newsletter.


About ERBA Diagnostics

ERBA Diagnostics, Inc., through its subsidiaries, develops, manufactures, and markets diagnostic test kits or assays, and automated systems that are used to aid in the detection of disease markers primarily in the areas of autoimmune, infectious diseases, clinical chemistry, hematology, and diabetes testing. It manufactures scientific and laboratory instruments, such as Mago 4, Mago 4S, and Mago Plus systems, which perform tests in an automated mode; sells other diagnostic products manufactured by third parties in Italy; and develops, manufactures, and markets raw materials, such as antigens that are used in the production of diagnostic kits. The company also develops, manufactures, and markets autoimmune reagents and research products for use by research laboratories and commercial diagnostic manufacturers. In addition, the company provides instruments for blood cell counting and blood analysis; supplies reagents and other consumable materials; sells diabetic testing products, including the DS5 instrument, dispenser, and associated reagent kits, which measure long-term glucose control in diabetic patients; and offers equipment for use in the field of human and veterinary hematology. Further, it manufactures and sells liquid stable, diagnostics chemistry reagents used for in vitro diagnostics testing. The company markets its products through its sales force to hospitals, reference laboratories, clinical laboratories, and research laboratories, as well as to other commercial companies that manufacture diagnostic products in the United States; and through sales representatives and independent agents in Italy, as well as through independent distributors internationally. The company was founded in 1980 and is headquartered in Miami Lakes, Florida. ERBA Diagnostics, Inc. is a subsidiary of ERBA Diagnostics Mannheim GmbH.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.83 out of 5 stars

Medical Sector

1230th out of 2,118 stocks

Pharmaceutical Preparations Industry

557th out of 832 stocks

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











ERBA Diagnostics (OTCMKTS:ERBA) Frequently Asked Questions

What stocks does MarketBeat like better than ERBA Diagnostics?

Wall Street analysts have given ERBA Diagnostics a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but ERBA Diagnostics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has ERBA Diagnostics' stock been impacted by COVID-19 (Coronavirus)?

ERBA Diagnostics' stock was trading at $0.28 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ERBA shares have decreased by 87.5% and is now trading at $0.0350.
View which stocks have been most impacted by COVID-19
.

Who are ERBA Diagnostics' key executives?

ERBA Diagnostics' management team includes the following people:
  • Mr. Suresh Vazirani, Exec. Chairman & MD (Age 69)
  • Mr. David Barka, Interim Chief Exec. Officer (Age 38)
  • Mr. Nate Wells, Chief Financial Officer
  • Dr. Chandra Krishnan, Sr. VP of Global Sales, Marketing and Bus. Devel.

Who are some of ERBA Diagnostics' key competitors?

What other stocks do shareholders of ERBA Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ERBA Diagnostics investors own include EKF Diagnostics (EKF), Auxly Cannabis Group (CBWTF), ContraFect (CFRX), Catalyst Pharmaceuticals (CPRX), ImmunoGen (IMGN), iQIYI (IQ), Myriad Genetics (MYGN), Nektar Therapeutics (NKTR), OHR Pharmaceutical (OHRP) and PDL BioPharma (PDLI).

What is ERBA Diagnostics' stock symbol?

ERBA Diagnostics trades on the OTCMKTS under the ticker symbol "ERBA."

How do I buy shares of ERBA Diagnostics?

Shares of ERBA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ERBA Diagnostics' stock price today?

One share of ERBA stock can currently be purchased for approximately $0.04.

What is ERBA Diagnostics' official website?

The official website for ERBA Diagnostics is www.erbadiagnostics.com.

Where are ERBA Diagnostics' headquarters?

ERBA Diagnostics is headquartered at 14100 Nw 57th Court, Miami Lakes FL, 33014.

How can I contact ERBA Diagnostics?

ERBA Diagnostics' mailing address is 14100 Nw 57th Court, Miami Lakes FL, 33014. The company can be reached via phone at 305-324-2300 or via email at [email protected]


This page was last updated on 6/25/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.